Literature DB >> 11254902

Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways.

S Ai1, M Kuzuya, T Koike, T Asai, S Kanda, K Maeda, T Shibata, A Iguchi.   

Abstract

Although Rho, a small GTPase, has been demonstrated to play an important role in the smooth muscle contraction and relaxation, little is known about the involvement of Rho protein in smooth muscle cell (SMC) migration. In this study the role of Rho-Rho kinase pathway was examined in SMC migration induced by platelet-derived growth factor (PDGF) and lysophosphatidic acid (LPA). C3 transferase, a specific inhibitor of Rho, blocked SMC migration induced by PDGF and LPA. Y-27632, a specific inhibitor of Rho kinase, a direct target molecule of Rho, inhibited PDGF and LPA-induced SMC migration in a concentration dependent manner. Although rapid increase in myosin light chain (MLC) phosphorylation in SMC treated with LPA was observed, no enhanced MLC phosphorylation was detected in response to PDGF. Y-27632 suppressed LPA-induced as well as basal level of MLC phosphorylation. ML-9, a specific inhibitor of myosin light chain kinase (MLCK), inhibited PDGF and LPA-induced SMC migration without the suppression of MLC phosphorylation at 5 min incubation, suggesting that MLCK may contribute to SMC migration via mechanism other than MLC phosphorylation. These results suggest that Rho-Rho kinase pathway is implicated in SMC migration and that different signaling pathways downstream of Rho-Rho kinase may be involved in LPA and PDGF-induced SMC migration. MLC phosphorylation via Rho-Rho kinase pathway appears to be implicated in LPA-dependent SMC migration. Whereas PDGF-mediated SMC migration is independent of increased MLC phosphorylation and other target molecules downstream of Rho-Rho kinase seem to be involved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254902     DOI: 10.1016/s0021-9150(00)00585-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction.

Authors:  Deepak Venkatesh; Natalie Fredette; Bahman Rostama; Yuefeng Tang; Calvin P H Vary; Lucy Liaw; Sumithra Urs
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-27       Impact factor: 8.311

3.  A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.

Authors:  Luciana B Lopes; Colleen M Brophy; Charles R Flynn; Zhengping Yi; Benjamin P Bowen; Christopher Smoke; Brandon Seal; Alyssa Panitch; Padmini Komalavilas
Journal:  J Vasc Surg       Date:  2010-09-22       Impact factor: 4.268

4.  CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.

Authors:  Dong An; Feng Hao; Fuqiang Zhang; Wei Kong; Jerold Chun; Xuemin Xu; Mei-Zhen Cui
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

5.  RhoA protects the mouse heart against ischemia/reperfusion injury.

Authors:  Sunny Yang Xiang; Davy Vanhoutte; Dominic P Del Re; Nicole H Purcell; Haiyun Ling; Indroneal Banerjee; Julie Bossuyt; Richard A Lang; Yi Zheng; Scot J Matkovich; Shigeki Miyamoto; Jeffery D Molkentin; Gerald W Dorn; Joan Heller Brown
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

6.  Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.

Authors:  Feng Hao; Fuqiang Zhang; Daniel Dongwei Wu; Dong An; Jing Shi; Guohong Li; Xuemin Xu; Mei-Zhen Cui
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-19       Impact factor: 4.249

7.  C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.

Authors:  Karen J Ho; Christopher D Owens; Thomas Longo; Xin X Sui; Cristos Ifantides; Michael S Conte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-11       Impact factor: 4.733

8.  The effect of lysophosphatidic acid on Toll-like receptor 4 expression and the nuclear factor-κB signaling pathway in THP-1 cells.

Authors:  Bo Yang; Zhibin Zhou; Xiaohao Li; Jianping Niu
Journal:  Mol Cell Biochem       Date:  2016-09-13       Impact factor: 3.396

9.  The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.

Authors:  Zhibin Zhou; Jianping Niu; Zhijun Zhang
Journal:  Mol Biol Rep       Date:  2009-09-16       Impact factor: 2.316

10.  Receptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activation.

Authors:  Zhi-Bin Zhou; Jian-Ping Niu; Zhi-Jun Zhang
Journal:  Int J Mol Sci       Date:  2009-07-13       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.